What Is the Dilution Table in an S-1? Calculating Changes in Net Tangible Book Value Per Share

The SEC’s Division of Corporation Finance has, since early 2024, intensified its scrutiny of dilution disclosures in S-1 filings, particularly for issuers with complex capital structures involving convertible instruments, warrants, and multiple classes of shares. This regulatory push follows a 2023 spike in shareholder lawsuits alleging inadequate disclosure of dilution mechanics in high-profile US IPOs, with settlements exceeding USD 150 million. For Hong Kong issuers pursuing a dual listing or a US-only offering, the dilution table—mandated under Item 506 of Regulation S-K—has become a critical focal point for SEC reviewers. The table’s primary function is to quantify the change in net tangible book value per share from the pre-offering to post-offering stage, a metric that directly impacts investor perception of value erosion. Missteps in its preparation, such as failing to account for the conversion of outstanding warrants or the exercise of over-allotment options, can trigger SEC comment letters that delay the offering timeline by 4 to 8 weeks. This article dissects the mechanical construction of the dilution table, its underlying regulatory framework, and the specific calculation pitfalls that Hong Kong issuers must address.

The Regulatory Mandate and Structural Logic of the Dilution Table

The dilution table is not a discretionary disclosure; it is a mandatory component of the prospectus summary in an S-1 filing, governed by Item 506 of Regulation S-K under the Securities Act of 1933, as amended. The SEC’s 2022 amendments to Regulation S-K, effective for filings after August 2023, did not alter the core requirement but clarified that the table must present the net tangible book value per share both before and after the offering, as well as the resulting dilution per share. For Hong Kong issuers accustomed to the HKEX Listing Rules—specifically Rule 8.08(1) regarding public float and Rule 2.03(2) on disclosure of material information—the US framework imposes a more formulaic and quantitative standard.

The starting point is the issuer’s net tangible book value, defined as total tangible assets minus total liabilities. Tangible assets exclude goodwill, intangible assets, and deferred tax assets. As of the most recent balance sheet date in the S-1, this figure is divided by the number of shares outstanding before the offering. The post-offering calculation incorporates the net proceeds from the offering, typically assuming the midpoint of the price range and full exercise of the underwriters’ over-allotment option. The dilution per share is the difference between the assumed offering price per share and the post-offering net tangible book value per share.

The SEC’s Staff Accounting Bulletin No. 120, issued in 2021, provides interpretive guidance on whether certain instruments—such as warrants or convertible notes—should be treated as common stock equivalents in the dilution calculation. The bulletin states that if an instrument is “in-the-money” by more than 20% at the time of filing, it must be included as a common stock equivalent in the diluted share count for the table. This is a stricter standard than the HKEX’s approach under the Hong Kong Financial Reporting Standards (HKFRS) for diluted earnings per share, which uses a more conservative threshold based on the average market price.

The Role of the Over-Allotment Option

The over-allotment option, or greenshoe, directly affects the dilution table. Under Section 4(2) of the Securities Act, the underwriters have the right to purchase up to 15% of the offered shares within 30 days of the offering. The dilution table must present two scenarios: one assuming no exercise of the over-allotment option, and one assuming full exercise. The SEC’s Division of Corporation Finance, in a 2023 comment letter to a Hong Kong biotech issuer, required the issuer to add a footnote explaining that the over-allotment option shares are treated as outstanding for the purpose of calculating post-offering net tangible book value per share, even though they may not be issued immediately.

Structural Components of the Dilution Table: A Line-by-Line Breakdown

The dilution table in a typical S-1 for a Hong Kong issuer follows a standardised format, but deviations in presentation have triggered SEC comment letters in 2024. The table is divided into three sections: pre-offering data, offering proceeds, and post-offering per-share calculations.

Pre-Offering Net Tangible Book Value

The first line states the net tangible book value as of the most recent balance sheet date. For a Hong Kong issuer structured as a Cayman Islands exempted company with a PRC operating subsidiary, this figure must be calculated on a consolidated basis under US GAAP or IFRS as issued by the IASB, as reconciled to US GAAP if required. The HKEX’s Listing Rule 4.08 requires financial statements to comply with HKFRS or IFRS, but the SEC mandates a reconciliation to US GAAP under Item 18 of Form 20-F for foreign private issuers. In a 2024 S-1 for a Shenzhen-based fintech company, the SEC requested a footnote clarifying that goodwill from a 2021 acquisition was excluded from the tangible asset calculation, reducing the pre-offering net tangible book value by USD 22.3 million.

Assumed Public Offering Price and Underwriting Discounts

The table uses an assumed public offering price, typically the midpoint of the price range disclosed in the S-1. The underwriting discounts and commissions, as well as estimated offering expenses (legal, accounting, printing, SEC registration fees), are deducted from the gross proceeds. For a Hong Kong issuer, the underwriting discount on a US IPO is typically 6.0% to 7.0% of the gross proceeds, compared to the 2.5% to 3.5% common on the HKEX Main Board under Rule 8.12. The SEC requires that the table disclose the net proceeds figure explicitly, with a breakdown in a footnote if the offering expenses exceed 3% of the gross proceeds.

The post-offering net tangible book value is calculated by adding the net proceeds to the pre-offering figure, then dividing by the total number of shares outstanding after the offering. This total includes the shares offered in the IPO, any shares issued upon conversion of outstanding convertible instruments, and shares issuable upon exercise of warrants or options that are in-the-money by more than 20%, per SAB 120. The dilution per share is the difference between the assumed offering price and this post-offering net tangible book value per share. In a sample calculation for a Hong Kong issuer with a pre-offering net tangible book value of HKD 500 million (USD 64.1 million) and an offering of 10 million shares at HKD 50 per share with a 7% underwriting discount, the dilution per share is HKD 47.15, representing a 94.3% dilution from the offering price.

Common Pitfalls for Hong Kong Issuers: Warrant Conversion and Dual-Class Structures

Hong Kong issuers often employ capital structures that introduce complexity into the dilution table. The SEC’s 2024 review of S-1 filings from Greater China companies has identified two recurring issues: the treatment of convertible instruments with anti-dilution provisions and the calculation of dilution for dual-class share structures.

Convertible Instruments and Anti-Dilution Clauses

Many Hong Kong issuers have issued convertible notes or preferred shares with anti-dilution clauses that adjust the conversion price upon the occurrence of a qualified IPO. These clauses are common in Series A and B financing rounds for PRC-based startups. Under SAB 120, if the conversion price adjustment is triggered by the IPO itself, the instrument must be treated as a common stock equivalent in the dilution table, regardless of whether it is in-the-money. In a 2024 comment letter to a Hong Kong-based e-commerce issuer, the SEC required the issuer to assume full conversion of all outstanding convertible notes at the adjusted conversion price, adding 8.5 million shares to the post-offering share count and increasing the dilution per share by HKD 3.20.

Hong Kong issuers listing on the NYSE or NASDAQ often adopt dual-class share structures, with Class A shares offered to the public and Class B shares held by founders, carrying 10 or 20 votes per share. The dilution table, however, must calculate net tangible book value per share on a per-share basis, treating all classes of common stock equally. The SEC’s 2023 rule on universal proxy cards does not directly affect the dilution table, but the SEC has issued guidance requiring a footnote explaining that the dilution per share does not account for the disparity in voting rights. For a Hong Kong issuer with 50 million Class A shares and 10 million Class B shares, the dilution per share is identical for both classes in the table, even though the economic dilution for Class A shareholders may be higher due to the voting premium embedded in Class B shares.

Practical Implications for Cross-Border Offerings and SPAC Transactions

The dilution table is equally relevant for Hong Kong issuers pursuing a traditional IPO or a de-SPAC transaction. In a SPAC merger, the dilution calculation must account for the sponsor’s promote shares, the exercise of warrants, and the redemption rights of public shareholders.

SPAC Dilution Mechanics

Under the SEC’s 2024 SPAC rules, effective January 2025, the dilution table in a de-SPAC transaction must disclose the impact of the sponsor’s promote shares, which are typically issued at a nominal price. For a Hong Kong issuer merging with a SPAC that has a USD 200 million trust, a sponsor promote of 20% of the post-merger equity, and warrants exercisable at USD 11.50 per share, the dilution per share can exceed 60% of the assumed merger consideration. The SEC’s 2024 rule requires the dilution table to present a pro forma net tangible book value per share assuming full redemption of all public shares, which is a scenario not typically required in a traditional IPO.

Comparison with HKEX Dilution Disclosure

The HKEX’s Listing Rules do not mandate a specific dilution table in the prospectus. Instead, Rule 11.04 requires a statement of the effect of the issue on the net tangible assets per share, but the format is less prescriptive. For a Hong Kong issuer conducting a dual primary listing on the HKEX and the NYSE, the S-1’s dilution table must reconcile with the HKEX prospectus disclosure. In a 2024 dual listing of a Shanghai-based semiconductor company, the HKEX prospectus showed a dilution of HKD 12.50 per share, while the S-1 showed a dilution of USD 1.60 per share, due to differences in the treatment of employee stock options under HKFRS versus US GAAP. The SEC required a reconciliation footnote explaining the discrepancy.

Actionable Takeaways for Hong Kong Issuers

Prepare a pre-filing dilution analysis under SAB 120, testing all outstanding convertible instruments and warrants for in-the-money status at the assumed offering price, and include a sensitivity analysis for the over-allotment option.
Reconcile the dilution table with the HKEX prospectus if pursuing a dual listing, and prepare a footnote explaining any differences arising from US GAAP versus HKFRS treatment of intangible assets and stock-based compensation.
Engage the underwriters’ counsel early to validate the treatment of anti-dilution clauses in convertible instruments, as the SEC’s 2024 comment letters have targeted issuers that exclude such instruments from the dilution calculation.
Model the dilution impact of the sponsor promote and warrant exercise in a SPAC transaction, assuming full redemption of public shares, as required under the SEC’s 2024 SPAC rules.
Disclose the voting rights disparity in a footnote for dual-class share structures, clarifying that the dilution per share does not reflect the economic dilution from the voting premium embedded in Class B shares.